Data / New clinical trials / Iceland
New clinical trials in Iceland: 21 since Nov 2024
The full list. New clinical trials with a site in Iceland: 21 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 1 row a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/iceland, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated October 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
21 clinical studies with a site in Iceland were first posted on ClinicalTrials.gov from January 17, 2025 to October 5, 2026; 7 have an industry sponsor and 12 are recruiting or about to. The newest, NCT07856862, was posted on October 5, 2026: Culturally Adapted Materials to Increase Cervical Cancer Screening Among Polish Women in Iceland (The Primary Health Care in the Capital Area).
The request: Every new clinical trial with a site in Iceland, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 21New trials
- 7Industry sponsored
- 12Recruiting or not yet
- October 5, 2026Latest posted
Newest trials
The newest 21 of 21, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| October 5, 2026 | NCT07856862 | Culturally Adapted Materials to Increase Cervical Cancer Screening Among Polish Women in Iceland | The Primary Health Care in the Capital Area | Not applicable | Not yet recruiting | Cervical Cancer Screening, Cervical Cancer, Cervical Cancer (Early Detection) | 2,000 | Iceland | clinicaltrials.gov |
| August 3, 2026 | NCT07741526 | Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD) | Arctic Therapeutics | Phase 2 | Active not recruiting | Alzheimer´s Disease | 33 | Denmark, Iceland | clinicaltrials.gov |
| July 21, 2026 | NCT07716865 | Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA) | Arctic Therapeutics | Phase 2 | Active not recruiting | Hereditary Cystatin C Amyloid Angiopathy (HCCAA), Hemorrhage Brain, Hemorrhage Cerebral | 15 | Iceland | clinicaltrials.gov |
| June 22, 2026 | NCT07659171 | Light Therapy for University Students | Reykjavik University | Not applicable | Completed | University Students, Sleep Problems, Well-being, Concentration Performance, Depression and Anxiety Symptom | 39 | Iceland | clinicaltrials.gov |
| April 8, 2026 | NCT07517263 | An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen... | Novartis Pharmaceuticals | Phase 3 | Active not recruiting | Cardiovascular Disease and Lipoprotein(a) | 5,700 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China... | clinicaltrials.gov |
| March 11, 2026 | NCT07465354 | OCD Summer Treatment Program for Adolescents in Iceland | University of Iceland | Not applicable | Recruiting | Obsessive-Compulsive Disorder (OCD) | 70 | Iceland | clinicaltrials.gov |
| March 11, 2026 | NCT07465159 | Multimodal Prehabilitation of Frail Patients Undergoing Elective Knee or Hip Replacement | University of Iceland | Not applicable | Recruiting | Frailty Syndrome, Prehabilitation, Arthroplasties, Knee Replacement, Arthroplasties, Hip Replacement | 50 | Iceland | clinicaltrials.gov |
| March 5, 2026 | NCT07452263 | Modified Essential Frailty Toolset in Older Adults Undergoing Major Elective Surgery | University of Iceland | Observational | Recruiting | Frailty in Adult Surgery, Frailty Syndrome, Elective Surgeries, Readmission Rates, Postoperative Complication | 250 | Iceland | clinicaltrials.gov |
| February 12, 2026 | NCT07408076 | Sodium Bicarbonate as an Alternative to Potassium Citrate for Kidney Stones | University of California, Los Angeles | Phase 1/2 | Not yet recruiting | Kidney Stones, Urolithiasis, Hypocitraturia, Nephrolithiasis | 30 | Canada, Iceland, United States | clinicaltrials.gov |
| January 30, 2026 | NCT07379359 | The ADHD Kids´ Study for Children 9-12 Years of Age | University of Iceland | Not applicable | Recruiting | Attention-Deficit/Hyperactivity Disorder (ADHD) | 100 | Iceland | clinicaltrials.gov |
| January 26, 2026 | NCT07367828 | Validity of Frailty Screening Tools as a Measure for Postoperative Outcomes | University of Iceland | Observational | Recruiting | Frailty in Adult Surgery, Frailty Syndrome, Elective Surgery | 350 | Iceland | clinicaltrials.gov |
| January 2, 2026 | NCT07314593 | Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults. | Landspitali University Hospital | Not applicable | Recruiting | Respiratory Infections | 400 | Iceland | clinicaltrials.gov |
| December 9, 2025 | NCT07273331 | Nursing Needs of Patients With Cirrhosis | Landspitali University Hospital | Observational | Enrolling by invitation | Cirrhoses, Liver | 150 | Iceland | clinicaltrials.gov |
| December 5, 2025 | NCT07266454 | Evaluating Stumble Recovery Functions of Prosthetic Knees | Össur Iceland ehf | Not applicable | Active not recruiting | Fall Prevention, Balance, Falls, Amputation of Lower Limb | 50 | Iceland | clinicaltrials.gov |
| September 16, 2025 | NCT07175714 | Evaluating Methods to Replicate Stumbles and Slips During Walking | Össur Iceland ehf | Not applicable | Recruiting | Fall Prevention, Balance, Falls, Amputation of Lower Limb | 20 | Iceland | clinicaltrials.gov |
| May 28, 2025 | NCT06992960 | Evaluation of the Scar Healing Effects of ChitoCare Medical Scar Healing Gel in Women Undergoing Breast Reduction or Mastopexy Surgery... | Primex ehf | Not applicable | Not yet recruiting | Surgical Scars | 39 | Iceland | clinicaltrials.gov |
| May 25, 2025 | NCT06989450 | Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer | Sidekick Health | Not applicable | Recruiting | Breast Cancer, Cancer | 140 | Iceland | clinicaltrials.gov |
| April 15, 2025 | NCT06929026 | Retinal Biomarkers in Parkinson´s Disease | Landspitali University Hospital | Observational | Active not recruiting | Parkinson Disease | 60 | Iceland | clinicaltrials.gov |
| April 8, 2025 | NCT06915493 | Blood Glucose Levels in Children During Anesthesia | Landspitali University Hospital | Observational | Completed | Fasting | 350 | Iceland | clinicaltrials.gov |
| April 2, 2025 | NCT06906133 | Sleep Quality and the Menstrual Cycle | University of Akureyri | Observational | Active not recruiting | Sleep Quality | 60 | Iceland | clinicaltrials.gov |
| January 17, 2025 | NCT06781879 | Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer | Jakob Kristian Jakobsen | Phase 4 | Recruiting | Non-Muscle Invasive Bladder Cancer | 272 | Denmark, Iceland, Norway, Sweden | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| University of Iceland | 5 | March 11, 2026 |
| Landspitali University Hospital | 4 | January 2, 2026 |
| Arctic Therapeutics | 2 | August 3, 2026 |
| Össur Iceland ehf | 2 | December 5, 2025 |
| The Primary Health Care in the Capital Area | 1 | October 5, 2026 |
| Reykjavik University | 1 | June 22, 2026 |
| Novartis Pharmaceuticals | 1 | April 8, 2026 |
| University of California, Los Angeles | 1 | February 12, 2026 |
| Primex ehf | 1 | May 28, 2025 |
| Sidekick Health | 1 | May 25, 2025 |
| University of Akureyri | 1 | April 2, 2025 |
| Jakob Kristian Jakobsen | 1 | January 17, 2025 |
Conditions
| Condition group | New trials | Latest |
|---|---|---|
| Frailty | 3 | March 11, 2026 |
| Dementia | 2 | August 3, 2026 |
| Uterine Cervical Neoplasms | 1 | October 5, 2026 |
| Cognitive Dysfunction | 1 | August 3, 2026 |
| Cerebral Amyloid Angiopathy, Familial | 1 | July 21, 2026 |
| Intracranial Hemorrhages | 1 | July 21, 2026 |
| Cerebral Hemorrhage | 1 | July 21, 2026 |
| Parasomnias | 1 | June 22, 2026 |
| Depression | 1 | June 22, 2026 |
| Anxiety Disorders | 1 | June 22, 2026 |
| Cardiovascular Diseases | 1 | April 8, 2026 |
| Myocardial Infarction | 1 | April 8, 2026 |
| Stroke | 1 | April 8, 2026 |
| Obsessive-Compulsive Disorder | 1 | March 11, 2026 |
| Postoperative Complications | 1 | March 5, 2026 |
| Kidney Calculi | 1 | February 12, 2026 |
| Urolithiasis | 1 | February 12, 2026 |
| Nephrolithiasis | 1 | February 12, 2026 |
| Calculi | 1 | February 12, 2026 |
| Attention Deficit Disorder with Hyperactivity | 1 | January 30, 2026 |
| Respiratory Tract Infections | 1 | January 2, 2026 |
| Common Cold | 1 | January 2, 2026 |
| Influenza, Human | 1 | January 2, 2026 |
| COVID-19 | 1 | January 2, 2026 |
| Breast Neoplasms | 1 | May 25, 2025 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 10 | October 5, 2026 |
| Observational | 6 | March 5, 2026 |
| Phase 2 | 2 | August 3, 2026 |
| Phase 3 | 1 | April 8, 2026 |
| Phase 1/2 | 1 | February 12, 2026 |
| Phase 4 | 1 | January 17, 2025 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.